Thermal therapy, Part 1: An introduction to thermal therapy

Critical Reviews in Biomedical Engineering

Volumn 34, Issue 6, 2006, Pages 459-489

  Habash, Riadh W Y ^a   Bansal, Rajeev ^b   Krewski, Daniel ^a   Alhafid, Hafid T ^c  

^a UNIVERSITY OF OTTAWA   (Canada)

^b UNIVERSITY OF CONNECTICUT   (United States)

^c AL GHURAIR UNIVERSITY   (United Arab Emirates)

Author keywords

EM bioeffects; EM exposure guidelines; EM risk assessment; Heat mechanisms; Side effects of heat

Indexed keywords

CARDIOLOGY; ELECTROMAGNETIC WAVES; ONCOLOGY; OPHTHALMOLOGY; PHYSICAL THERAPY; THERMAL CONDUCTIVITY; ULTRASONIC WAVES; UROLOGY;

EM BIOEFFECTS; EM EXPOSURE GUIDELINES; EM RISK ASSESSMENT; HEAT MECHANISMS; THERMAL THERAPY; THERMOTHERAPEUTICAL APPLICATIONS;

PATIENT TREATMENT;

BEHAVIOR; BIOLOGICAL ACTIVITY; CANCER; CARCINOGENICITY; CARDIOVASCULAR SYSTEM; CELL KILLING; CRYOTHERAPY; DIATHERMY; ELECTROMAGNETIC FIELD; ELECTROMAGNETIC RADIATION; ENERGY RESOURCE; HUMAN; HYPERTHERMIA; HYPERTHERMIC THERAPY; IMMUNE SYSTEM; NERVOUS SYSTEM; NONHUMAN; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SURGICAL TECHNIQUE; TEMPERATURE; TEMPERATURE SENSITIVITY; THERMAL ABLATION; THERMAL INJURY; TUMOR;

EID: 34347218982     PISSN: 0278940X     EISSN: None     Source Type: Journal    
DOI: 10.1615/CritRevBiomedEng.v34.i6.20     Document Type: Review

References (155)

1. Nikfarjam M, Muralidharan V, Christophi C. Mechanisms of focal heat destruction of liver tumors. J Surg Res. 2005;127:208-23.
2. Strezer F. Microwave medical devices. IEEE Microwave Mag. 2002;3:65-70.
3. Rosen A, Stuchly MA, Vander Vorst A. Applications of RF/microwaves in medicine. IEEE Trans Microw Theory Tech. 2002;50:963-74.
4. Vander Vorst A, Rosen A, Kotsuka Y. RF/microwave interaction with biological tissues. New York: Wiley-IEEE; 2006.
5. Stauffer PR, Goldberg SN. Introduction: thermal ablation therapy. Int J Hyperthermia. 2004;7:671-7.
6. Michaelson S, Lin, JC. Biological effects and health implications of radio frequency radiation. New York: Plenum; 1987.
7. Thuery J. Microwaves-industrial, scientific and medical applications. Norwood, MA: Artech House; 1992.
8. Rosen A, Rosen HD. New frontiers in medical device technology. New York: Wiley; 1995.
9. Polk C, Postow E. Handbook of biological effects of electromagnetic fields. Boca Raton: CRC Press; 1996.
10. Habash RWY. Electromagnetic fields and radiation: human bioeffects and safety. New York: Marcel Dekker; 2001.
11. Habash RWH, Brodsky LM, Leiss W, Krewski DK, Repacholi M. Health risk of electromagnetic fields. Part II: Evaluation and assessment of radio frequency radiation. Crit Rev Biomed Eng. 2003;31:197-254.
12. Dewhirst MW, Lora-Michiels M, Viglianti BL, Dewey WC, Repacholi M. Carcinogenic effects of hyperthermia. Int J Hyperthermia. 2003;19:236-51.
13. Haveman J, van der zee J, Wondergem J, Hoogeveen JF, Mulshof MC. Effects of hyperthermia on the peripheral nervous system: a review. Int J Hyperthermia. 2004;20:371-91.
14. Stauffer PR. Evolving technology for thermal therapy of cancer. Int J Hyperthermia. 2005;21:731-44.
15. Ayrapetyan S, Markov M. Bioelectromagnetics: current concepts. Berlin: Springer-Verlag; 2006.
16. Vander Vorst A. RF/Microwave radiation protection. TUTB Newslett. 2003;21: 12-6.
17. Lai H. Research on the neurological effects of nonionizing radiation at the University of Washington. Bioelectromagnetics. 1992;13: 513-26.
18. Dimbylow PJ. FDTD calculations of SAR for a dipole closely coupled to the head at 900 MHz and 1.9 GHz. Phys Med Biol. 1993;38: 361-8.
19. Dimbylow PJ, Mann JM. SAR calculations in an anatomically realistic model of the head for mobile communication transceivers at 900 MHz and 1.8 GHz. Phys Med Biol. 1994;39: 1527-53.
20. Martens LJ, DeMoerloose C, DeWagter, DeZutter D. Calculation of the electromagnetic fields induced in the head of an operator of a cordless telephone. Radio Sci. 1995;30: 415-20.
21. Habash RWY. Electromagnetics?the uncertain health risks. IEEE Potentials. 2003;22:23-6.
22. Kheifets L, Repacholi A, Saunders R. Thermal stress and radiation protection principles. Int J Hyperthermia. 2003;19: 215-24.
23. IEEE. Safety levels with respect to human exposure to radio frequency electromagnetic fields, 3 kHz to 300 GHz. IEEE Standard C95.1-1991, 1992.
24. IEEE. Standard for safety levels with respect to human exposure to radio frequency electromagnetic fields, 3 kHz to 300 GHz. IEEE Standard C95.1-1991, 1999.
25. IEEE. Recommended practice for determining the peak spatial-average specific absorption rate (SAR) in the human head from wireless communications devices. IEEE Standard 1528-2003, 2003.
26. IEEE. Standard for safety levels with respect to human exposure to radio frequency electromagnetic fields, 3 kHz to 300 GHz. IEEE Std C95.1-2005, 2006.
27. NRPB. Board statement on restrictions on human exposure to static and time?varying electromagnetic fields. Vol 4 (5). National Radiological Protection Board, Chilton, Didcot, Oxon, UK, 1993.
28. NRPB. ICNIRP guidelines for limiting exposure to time?varying electric, magnetic and electromagnetic fields (up to 300 GHz): advice on aspects of implementation in the UK. National Radiological Protection Board, Chilton, Didcot, Oxon, UK, 1999.
29. NRPB. Possible health effects from terrestrial trunked radio (TETRA). Report of an advisory group on non-ionising Radiation. National Radiological Protection Board, Chilton, Didcot, Oxon, UK, 2001.
30. NRPB. Review of the scientific evidence for limiting exposure to electromagnetic fields (80-300 GHz). National Radiological Protection Board, Chilton, Didcot, Oxon, UK, 2004.
31. FCC. Guidelines for evaluating the environmental effects of radio frequency radiation. Federal Communications Commission, 96-326, Washington, DC, 1996.
32. ICNIRP. Guidelines for limiting exposure to time?varying electric, magnetic and electromagnetic fields (up to 300GHz). Health Phys. 1998a;74:494-522.
33. ICNIRP. Responses to questions and comments on ICNIRP. Health Phys. 1998b;75: 438-9.
34. ICNIRP. General approach to protection against non-ionizing radiation. Health Phys. 2002;82:540-8.
35. Safety Code 6. Limits of human exposure to radiofrequency electromagnetic fields in the frequency range from 3 kHz to 300 GHz. Environmental Health Directorate, Health Protection Branch, Health Canada, Canada, 1999.
36. ARPANSA. Maximum exposure levels to radiofrequency fields?3 kHz?300 GHz. Radiation Protection. Series No. 3. Australian Radiation Protection and Nuclear Safety Agency, Australia, 2002.
37. CEC. Council recommendations on the limitation of exposure of the general public to electromagnetic fields (0 Hz to 300 GHz). J Eur Communities. 1999;L199:59-70.
38. Seegenschmiedt MH, Vernon CC. A historical perspective on hyperthermia in oncology. In: Seegenschmiedt MH, Fessenden P, Vernon CC, Editors. Thermoradiotherapy and thermochemotherapy Volume 1. Berlin: Springer Verlag; 1995. p. 3-44.
39. Diederich CJ. Thermal ablation and high-temperature thermal therapy: overview of technology and clinical implementation. Int J Hyperthermia. 2005;21:745-53.
40. Dewey WC. Arrhenius relationships from the molecule and cell to the clinic. Int J Hyperthermia. 1994;10: 457-83.
41. Field SB, Morris CC. The relationship between heating time and temperature: its relevance to clinical hyperthermia. Radiother Oncol. 1983;1:179-86.
42. Sapareto SA, Dewey WC. Thermal dose determination in cancer therapy. Int J Radiat Oncol Biol Phys. 1984;10: 787-800.
43. Short JG, Turner PF. Physical hyperthermia and cancer therapy. Proc IEEE. 1980;68:133-42.
44. Cheung AY. Microwave hyperthermia for cancer therapy. IEE Proc. 1987;34:493-522.
45. Dewhirst MW, Griffin TW, Smith AR, Parker RG, Hanks GE, Brady LW. Intersociety council on radiation oncology essay on the introduction of new medical treatments into practice. J Natl Cancer Inst. 1993;85:951-7.
46. Dewhirst MW, Vujaskovic Z, Jones E, Thrall D. Re-setting the biologic rationale for thermal therapy. Int J Hyperthermia. 2005;21:779-90.
47. Lepock JR. How do cells respond to their thermal environment? Int J Hyperthermia. 2005;21:681-7.
48. Lepock JR. Cellular effects of hyperthermia: relevance to the minimum dose for thermal damage. Int J Hyperthermia. 2003;19:252-66.
49. Miles CA. Relating cell killing to inactivation of critical components. Appl Environ Microbiol. 2006;72: 914-7.
50. Welch AJ, Motamedi M, Rastegar S, Le Carpentier GL, Jansen D. Laser thermal ablation. Photochem Photobiol. 1991;53:815-23.
51. Germer CT, Roggan A, Ritz JP, Isbert C, Albrecht D, Muller G, Buhr HJ. Optical properties of native and coagulated human liver tissue and liver metastases in the near infrared range. Lasers Surg Med. 1998;23:194-203.
52. Haemmerich D, Laeseke PF. Thermal tumour ablation: devices, clinical applications and future directions. Int J Hyperthermia. 2005;21:755-60.
53. Nikfarjam M, Muralidharan V, Christophi C. Focal hyperthermia produces progressive tumor necrosis independent of the initial thermal effects. J Gastrointest Surg. 2005;9:410-7.
54. Tropea BI, Lee RC. Thermal injury kinetics in electrical trauma. J Biomech Eng. 1992;114:241-50.
55. Pennes HH. Analysis of tissue and arterial blood temperatures in the resting human arm. J Appl Physiol. 1948;1:93-122.
56. Dickson JA, Calderwood SK. Temperature range and selective sensitivity of tumors to hyperthermia: A critical review. Ann N Y Acad Sci .1980;335:180-205.
57. Overgaard K, Overgaard J. Investigations on the possibility of a thermic tumor therapy. I. Short-wave treatment of a transplanted isologous mouse mammary carcinoma. Eur J Cancer. 1972;8:65-78.
58. Christensen DA, Durney CH. Hyperthermia production for cancer therapy: a review of fundamentals and methods. J Microw Power. 1981;16: 89-105.
59. Cheung AY, Neyzari A. Deep local hyperthermia for cancer therapy: external electromagnetic and ultrasound techniques. Cancer Res. 1984;44: 4736s-44s.
60. Fessenden P, Hand JW. Hyperthermia therapy physics. In: AR Smith, Editor. Medical radiology: radiation therapy physics. Berlin: Springer-Verlag;1995. p. 315-63.
61. Roemer RB. Engineering aspects of hyperthermia therapy. Ann Rev Biomed Eng. 1999;1: 347-76.
62. Gel'vich EA, Mazokhin VN. Technical aspects of electromagnetic hyperthermia in medicine. Crit Rev Biomed Eng. 2001;29:77-97.
63. Moroz P, Jones SK, Gray BN. Magnetically mediated hyperthermia: current status and future directions. Int J Hyperthermia. 2002;18: 267-84.
64. Dewhirst MW, Viglianti BL, Lora-Michiels M, Hanson M, Hoopes PJ. Basic principles of thermal dosimetry and thermal thresholds for tissue damage from hyperthermia. Int J Hyperthermia. 2003;19:267-94.
65. Haemmerich D, Lee FT Jr, Schutt DJ, Sampson LA, Webster JG, Fine JP, Mahvi DM. Large-volume radiofrequency ablation of ex vivo bovine liver with multiple cooled cluster electrodes. Radiology. 2005;234:563-8.
66. Nussbaum GH, editor. Physical aspects of hyperthermia. New York: American Association of Physicists in Medicine; 1982.
67. Field SB, Hand JW, editors. An introduction to the practical aspects of clinical hyperthermia. London: Taylor & Francis; 1990.
68. Gautherie M, editor. Methods of external hyperthermia heating. Berlin: Springer-Verlag; 1990.
69. Osepchuk JM, Petersen RC. Safety and environmental issues. In: Golio M, Editor. Modern microwave and RF handbook. Boca Raton, FL: CRC Press; 2001. p. 3.28-43.
70. Song CW. Effect of hyperthermia on vascular functions of normal tissues and experimental tumors. Brief communication. J Natl Cancer Inst. 1978;60:711-3.
71. Vaupel P, Kallinowski F. Physiological effects of hyperthermia. In: Streffer C, Editor. Recent results in cancer reasearch. Vol 104. Berlin: Springer-Verlag; 1987. pp. 71-109.
72. Horsman MR. Tissue physiology and the response to heat. Int J Hyperthermia. 2006;22:197-203.
73. Patterson J, Strang R. The role of blood flow in hyperthermia. Int J Radiat Oncol Biol Phys. 1979;5:235-41.
74. Vernon CC, Hand JW, Field SB, Machin D, Whaley JB, van der Zee J, van Putten WL, van Rhoon GC, van Dijk JD, Gonzalez Gonzalez D, Liu FF, Goodman P, Sherar M. Radiotherapy with or without hyperthermia in the treatment of superficial localized breast cancer: results from five randomized controlled trials. International Collaborative Hyperthermia Group. Int J Radiat Oncol Biol Phys. 1996;35:731-44.
75. Goldstein LS, Dewhirst MW, Repacholi M, Kheifets L. Summary, conclusions and recommendations: adverse temperature levels in the human body. Int J Hyperthermia. 2003;19:373-84.
76. Nelson DA, Nelson MT, Walters TJ, Mason PA. Skin heating effects of millimeter-wave irradiation-thermal modeling results. IEEE Trans Microw Theory Tech. 2000;48:2111-20.
77. Fajardo LE, Egbert B, Marmor J, Hahn GM. Effects of hyperthermia in the malignant tumor. Cancer. 1980;45;613-23.
78. Dikomy E, Franzke J. Effect of heat on induction and repair of DNA strand breaks in X-irradiated CHO cells. Int J Radiat Biol. 1992;61:221-34.
79. Sakaguchi Y, Stephens LC, Makino M, Kaneko T, Strebel FR, Danhauser LL, Jenkins GN, Bull JM. Apoptosis in tumors and normal tissues induced by whole body hyperthermia in rats. Cancer Res. 1995;55:5459-64.
80. Roti Roti JL, Kampinga HH, Malyapa RS, Wright WD, vanderWaal RP, Xu M. Nuclear matrix as a target for hyperthermic killing of cancer cells. Cell Stress Chaperones. 1998;3:245-55.
81. Sawaji Y, Sato T, Takeuchi A, Hirata M, Ito A. Anti-angiogenic action of hyperthermia by suppressing gene expression and production of tumour-derived vascular endothelial growth factor in vivo and in vitro. Br J Cancer. 2002;86:1597-603.
82. Laszlo A. The effects of hyperthermia on mammalian cell structure and function. Cel Prolif. 1992;25:59-87.
83. Kampinga HH, Dynlacht JR, Dikoney E, Mechanism of radiosensitization by hyperthermia (≥ 43°C) as derived from studies with DNA repair defective mutant cell lines. Int J Hyperthermia. 2004;20:131-9.
84. Kregel KC. Heat shock proteins: modifying factors in physiological stress responses and acquired thermotolerance. J Appl Physiol. 2002;92: 2177-86.
85. Sharp FR, Massa SM, Swanson RA. Heat-shock protein protection. Trends Neurosci. 1999;22:97-9.
86. Sherman MY, Goldberg AL. Cellular defenses against unfolded proteins: a cell biologist thinks about neurodegenerative diseases. Neuron. 2001;29:15-32.
87. Klostergaard J, Barta M, Tomasovic SP. Hyperthermic modulation of tumor necrosis factor-dependent monocyte/macrophage tumor cytotoxicity in vitro. J Biol Response Mod. 1989;8:262-77.
88. Tomasovic SP, Klostergaard J. Hyperthermic modulation of macrophage-tumor cell interactions. Cancer Metastasis Rev. 1989: 8:215-29.
89. Isbert C, Ritz JP, Roggan A, Schuppan D, Ruhl M, Buhr HJ, Germer CT. Enhancement of the immune response to residual intrahepatic tumor tissue by laserinduced thermotherapy (LITT) compared to hepatic resection. Lasers Surg Med. 2004;35:284-92.
90. Hand JW, Walker H, Hornsey S, Field SB. Effects of hyperthermia on the mouse testis and its response to X-rays, as assayed by weight loss. Int J Radiat Biol. 1979;35:521-8.
91. Collins P, Lacy D. Studies on the structure and function of the mammalian testis. II. Cytological and histochemical observations on the testis of the rat after a single exposure to heat applied for different lengths of time. Proc R Soc Lond B Biol Sci. 1969;172:17-38.
92. Baranski B. Effects of the workplace on fertility and related reproductive outcomes. Environ Health Perspect. 1993;1019(suppl 2):81-90.
93. Mieusset R, Bujan L. Testicular heating and its possible contributions to male infertility: a review. Int J Androl. 1995;18:169-84.
94. Jannes P, Spiessens C, Van der Auwera I, D'Hooghe T, Verhoeven G, Vanderschueren D. Male subfertility induced by acute scrotal heating affects embryo quality in normal female mice. Hum Reprod. 1998;13:372-5.
95. Setchell BP, D'Occhio MJ, Hall MJ, Laurie MS, Tucker MJ, Zupp JL. Is embryonic mortality increased in normal female rats mated to subfertile males? J Reprod Fertil. 1998;82:567-74.
96. Rockett JC, Mapp FL, Garges JB, Christopher Luft J, Mori C, Dix DJ. Effects of hyperthermia on spermatogenesis, apoptosis, gene expression, and fertility in adult male mice. Biol Reprod. 2001;65:229-39.
97. Shen RN, Lu L, Shidnia H, Hornback NB, Broxmeyer HE. Influence of elevated temperature on natural killer cell activity and lectin-dependent cytotoxicity of human umbilical cord blood and adult blood cells. Int J Radiat Oncol Biol Phys. 1994;29:821-6.
98. Multhoff G, Botzler C, Jennen L, Schmidt J, Ellwart J, Issels R. Heat shock protein 72 on tumor cells: a recognition structure for natural killer cells. J Immunol. 1997;158:4341-50.
99. Yoshioka A, Miyachi Y, Imamura S. Immunological effects of in vitro hyperthermia. J Clin Lab Immunol. 1989;29:95-7.
100. Roberts NJ Jr. Differential effects of hyperthermia on human leukocyte production of interferon-alpha and interferon-gamma. Proc Soc Exp Biol Med. 1986;183:42-7.
101. Downing JF, Taylor MW, Wei KM, Elizondo RS. In vivo hyperthermia enhances plasma antiviral activity and stimulates peripheral lymphocytes for increased synthesis of interferon-gamma. J Interferon Res. 1987;7:185-93.
102. Alfieri AA, Hahn EW, Kim JH. Role of cell-mediated immunity in tumor eradication by hyperthermia. Cancer Res. 1981;41:1301-5.
103. Mansoor S, Spano M, Baschieri S, Cividalli A, Mosiello L, Doria G. Effect of in vivo hyperthermia on thymocyte maturation and selection. Int Immunol. 1992;4:227-32.
104. Moliterno R, Woan M, Bentlejewski C, Qian J, Zeevi A, Pham S, Griffith BP, Duquesnoy RJ. Heat shock protein-induced T-lymphocyte propagation from endomyocardial biopsies in heart transplantation. J Heart Lung Transplant. 1995;14:329-37.
105. Ito A, Shinkai M, Honda H, Wakabayashi T, Yoshida J, Kobayashi T. Augmentation of MHC class I antigen presentation via heat shock protein expression by hyperthermia. Cancer Immunol Immunother. 2001;50: 515-22.
106. Asea A, Kraeft SK, Kurt-Jones EA, Stevenson MA, Chen LB, Finberg RW, Koo GC, Calderwood SK. HSP70 stimulates cytokine production through a CD14-dependent pathway, demonstrating its dual role as a chaperone and cytokine. Nat Med. 2000;6:435-42.
107. Calderwood SK, Asea A. Targeting HSP70-induced thermotolerance for design of thermal sensitizers. Int J Hyperthermia. 2002;18: 597-608.
108. Ivarsson K, Myllymaki L, Jansner K, Bruun A, Stenram U, Tranberg KG. Heat shock protein 70 (HSP70) after laser thermotherapy of an adenocarcinoma transplanted into rat liver. Anticancer Res. 2003;23:3703-12.
109. Srivastava P. Roles of heat-shock proteins in innate and adaptive immunity. Nat Rev Immunol. 2002;2:185-94.
110. Li Z, Menoret A, Srivastava P. Roles of heat-shock proteins in antigen presentation and cross-presentation. Curr Opin Immunol. 2002;14:45-51.
111. Milani V, Noessner E. Effects of thermal stress on tumor antigenicity and recognition by immune effector cells. Cancer Immunol Immunother. 2006;55: 312-9.
112. Donaldson GC, Keating WR, Saunders RD. Cardiovascular responses to heat stress and their adverse consequencies in healthy and vulnerable human populations. Int J Hyperthermia. 2003;19:225-35.
113. Gong B, Asimakis GK, Chen Z, Albrecht TB, Boor PJ, Pappas TC, Bell B, Motamedi M. Whole-body hyperthermia induces up-regulation of vascular endothelial growth factor accompanied by neovascularization in cardiac tissue. Life Sci. 2006;79:1781-8.
114. Gowda A, Yang CJ, Asimakis GK, Ruef J, Rastegar S, Runge MS, Motamedi M. Cardioprotection by local heating: improved myocardial salvage after ischemia and reperfusion. Ann Thorac Surg. 1998;65:1241-7.
115. Khan VR, Brown IR. The effect of hyperthermia on the induction of cell death in brain, testis, and thymus of the adult and developing rat. Cell Stress Chaperones 2002;7:73-90.
116. Haveman J, Smina P, Wondergem J, van der zee J, Mulshof MCCM. Effects of hyperthermia on the central nervous system: what was learnt from animal studies? Int J Hyperthermia. 2005;21:473-87.
117. Takahashi S, Tanaka R, Watanabe M, Takahashi H, Kakinuma K, Suda T, Yamada M, Takahashi H. Effects of whole-body hyperthermia on the canine central nervous system. Int J Hyperthermia. 1999;15:203-16.
118. Hoogenveen JF, Troost D, Wondergem J, van der Krachi AH, Haveman J. Hyperthermic injury versus crush injury in the rat sciatic nerve: a comparative functional, histopathological and morphometrical study. J Neurol Sci. 1992;108:55-64.
119. Sasaki M, Ide C. Demyelination and remyelination in the doesal funiculus of the rat spinal cord after heat injury. J Neurocytol. 1989;18:225-39.
120. De Vrind HH, Wondergem J, Haveman J. Hyperthermia-induced damage to rat sciatic nerve assessed in vivo with functional methods and with electrophysiology. J Neurosci Methods. 1992;45:165-74.
121. Vujaskovic Z, Gillette SM, Powers BE, Larue SM, Gillete EL, Borak TB, Scott RJ, Ryan TB, Colacchio TA. Effects of intraoperative hyperthermia on peripheral nerves: neurological and electrophysiological studies. Int J Hyperthermia. 1994;10:41-9.
122. Hogenveen JF, Troost D, van der Kracht AH. Wondergen J, Haveman J, Gonzalez Gonzalez D. Ultrastructural changes in the rat sciatic nerve after local hyperthermia. Int J Hyperthermia. 1993;9:723-30.
123. Sminia P, Van der Zee J, Wondergem J, Haveman J. Effect of hyperthermia on the central nervous system: a review. Int J Hyperthermia 1994;10:1-130.
124. Sharma HS, Hoopes PJ. Hyperthermia induced pathophysiology of the central nervous system. Int J Hyperthermia. 2003;19:325-54.
125. Bull JM, Lees D, Schuette W, Whang-Peng J, Smith R, Bynum G, Atkinson ER, Gottdiener JS, Gralnick HR, Shawker TH, DeVita VT, Jr. Whole body hyperthermia: a phase-I trial of a potential adjuvant to chemotherapy. Ann Intern Med. 1979;90:317-23.
126. D'Andrea JA, Adair ER, de Lorge JO. Behavioral and cognitive effects of microwave exposure. Bioelectromagnetics. 2003;24:S39-S62.
127. Dhahi SJ, Habash RWY, Alhafid HT. Lack of mutagenic effects on conidia of aspergillus amstelodami irradiated by 8.7175 GHz microwaves. J Microw Power. 1982;17:346-51.
128. Ned B, Hornback MD. Is the community radiation oncologist ready for clinical hyperthermia? RadioGraphics. 1987;7:139-49.
129. Weston A, Harris CC. Chemical carcinogenesis. In: Bast RC, Kufe DW, Pollock RE, Weichselbaum RR, Holland JF, Frei E, Editors. Cancer medicine. 5 ed. Hamilton: Decker;2000. p. 189-94.
130. Baker DG, Constable WC, Sager H. The effect of hyperthermia on radiationinduced carcinogenesis. Radiat Res. 1988;115:448-60.
131. Sminia P, Haveman J, Jansen W, Hendriks JJ, van Dijk JD. Hyperthermia promotes the incidence of tumours following X-irradiation of the rat cervical cord region. Int J Radiat Biol. 1991;60:833-45.
132. Sminia P, van der Kracht AHW, Frederiks WM, Jansen W. Hyperthermia, radiation carcinogenesis and the protective potential of vitamin A and N-acetylcysteine. J Cancer Res Clin Oncol. 1996;122:343-50.
133. Eki T, Enomoto T, Murakami Y, Hanaoka F, Yamada M. Characterization of chromosome aberrations induced by incubation at a restrictive temperature in the mouse temperature-sensitive mutant tsFT20 strain containing heat-labile DNA polymerase alpha. Cancer Res. 1987;47:5162-70.
134. Mackey MA, Dewey WC. Time-temperature analysis of cell killing of synchronous G1 and S phase Chinese hamster cells in vitro. Radiat Res. 1988;113:318-33.
135. Dewey WC, Li XL, Wong RS. Cell killing, chromosomal aberrations, and division delay as thermal sensitivity is modified during the cell cycle. Radiat Res. 1990;122: 268-74.
136. Li XL, Wong RS, Dewey WC. Thermal tolerance during S phase for cell killing and chromosomal aberrations. Radiat Res. 1990;122:193-6.
137. Nevaldine B, Longo JA, Hahn PJ. Hyperthermia inhibits the repair of DNA doublestrand breaks induced by ionizing radiation as determined by pulsed-field gel electrophoresis. Int J Hyperthermia. 1994;10:381-8.
138. Wong RS, Dynlacht JR, Cedervall B, Dewey WC. Analysis by pulsed-field gel electrophoresis of DNA double-strand breaks induced by heat and/or X-irradiation in bulk and replicating DNA of CHO cells. Int J Radiat Biol. 1995;68: 141-52.
139. Wachsberger PR, Iliakis G. Hyperthermia does not affect rejoining of DNA double-strand breaks in a cell-free assay. Int J Radiat Biol. 2000;76:313-26.
140. Lindquist S. Heat-shock proteins and stress tolerances in microorganisms. Curr Opin Genet Dev. 1992;2:748-55.
141. Waters ER, Schaal BA. Heat shock induces a loss of rRNA-encoding DNA repeats in Brassica nigra. Proc Natl Acad Sci USA. 1996;93:1449-52.
142. Leonhardt EA, Trinh M, Forrester HB, Johnson RT, Dewey WC. Comparisons of the frequencies and molecular spectra of HPRT mutants when human cancer cells were X-irradiated during G1 or S phase. Radiat Res. 1997;148:548-60.
143. Davidson JF, Schiestl RH. Cytotoxic and genotoxic consequences of heat stress are dependent on the presence of oxygen in Saccharomyces cerevisiae. J Bacteriol. 2001;83: 4580-7.
144. Mason PA, Walters TH, DiGiovanni J, Beason CW, Jauchem JR, Dick, Jr EJ, Mahajan K, Dusch SJ, Shields BA, Merritt JH, Murphy MR, Ryan KL. Lack of effect of 94 GHz radio frequency radiation exposure in an animal model of skin carcinogenesis. Carcinogenesis. 2001;22:1701-8.
145. Mitchel REJ, Morrison DP, Gragtmans NJ, Jevcak JJ. Hyperthermia and phorbol ester tumor promotion in mouse skin. Carcinogenesis. 1986;7: 1505-10.
146. Mitchel REJ, Morrison DP, Gragtmans NJ. Tumorigenesis and carcinogenesis in mouse skin treated with hyperthermia during stage I or stage II of tumor promotion. Carcinogenesis. 1987;8;1875-9.
147. Mitchel RE, Morrison DP, Gragtmans NJ, The influence of a hyperthermia treatment on chemically induced tumor initiation and progression in mouse skin. Carcinogenesis. 1988;9:379-85.
148. IEGMP. Mobile phones and health. National Radiological Protection Board. Chilton, Didcot, Oxon, UK, 2000.
149. Toler JC, Shelton WW, Frei MR, Merritt JH, Stedham MA. Long-term, low-level exposure of mice prone to mammary tumors to 435 MHz radiofrequency radiation. Radiat Res. 1997;148: 227-34.
150. Frei MR, Berger RE, Dusch SJ, Guel V, Jauchem JR, Merritt JH, Stedham MA. Chronic exposure of cancer-prone mice to low-level 2450 MHz radiofrequency radiation. Bioelectromagnetics. 1998;19:20-31.
151. Imaida K, Taki M, Watanabe S, Kamimura Y, Ito T, Yamaguchi T, Ito N, Shirai T. The 1.5 GHz electromagnetic near-field used for cellular phones does not promote rat liver carcinogenesis in a medium-term liver bioassay. Jpn J Cancer Res. 1998;89:995-1002.
152. Repacholi MH, Basten A, Gebski V, Noonan D, Finnie J, Harris AW. Lymphomas in Eμ-Pim 1 transgenic mice exposed to pulsed 900 MHz electromagnetic fields. Radiat Res. 1997;147:631-40.
153. Adey WR, Byus CV, Cain CD, Higgins RJ, Jones RA, Kean CJ, Kuster N, MacMurray A, Stagg RB, Zimmerman G. Spontaneous and nitrosourea-induced primary tumors of the central nervous system in Fischer 344 rats exposed to frequency-modulated microwave fields. Cancer Res. 2000;60:1857-63.
154. Feychting M, Ahlbom A, Kheifets L. EMF and health. Ann Rev Public Health. 2005;26:165-89.
155. Tell RA, Harlen F. A preview of selected biological effects and dosimetric data useful for development of radiofrequency safety standards for human exposure. J Microw Power. 1979;14:405-24.